Comprehensive determination of the solid state stability of bethanechol chloride active pharmaceutical ingredient using combined analytical tools
ROTIVAL, Romain
Laboratoire Physico-Chimie Industrielle du Médicament [LPCIM]
Laboratoire de Contrôle Qualité
Voir plus >
Laboratoire Physico-Chimie Industrielle du Médicament [LPCIM]
Laboratoire de Contrôle Qualité
ROTIVAL, Romain
Laboratoire Physico-Chimie Industrielle du Médicament [LPCIM]
Laboratoire de Contrôle Qualité
< Réduire
Laboratoire Physico-Chimie Industrielle du Médicament [LPCIM]
Laboratoire de Contrôle Qualité
Langue
en
Article de revue
Ce document a été publié dans
CrystEngComm. 2013, vol. 15, n° 39, p. 7970-7980
Royal Society of Chemistry
Résumé en anglais
The use of an integrative analytical approach allowed us to establish the intrinsic solid state stability of bethanechol chloride (BC), an active pharmaceutical ingredient used in the treatment of urinary retention. First, ...Lire la suite >
The use of an integrative analytical approach allowed us to establish the intrinsic solid state stability of bethanechol chloride (BC), an active pharmaceutical ingredient used in the treatment of urinary retention. First, the crystal structure of the monoclinic form has been described using single crystal X-ray diffraction studies. Second, thermal analyses revealed that the compound degrades upon melting, with an apparent melting temperature estimated to be 231 °C. No transition from the monoclinic to the orthorhombic form has been observed, suggesting that the monoclinic form is the stable one. Third, the two-step melting–decomposition process has been elucidated by liquid chromatography and thermogravimetry coupled to mass spectrometry. The first step corresponds to the sample liquefaction, which consists of the gradual dissolution of bethanechol chloride in its liquid degradant, i.e. betamethylcholine chloride. This step is in agreement with Bawn kinetics and the activation energy of the reaction has been estimated at 35.5 kcal mol−1. The second step occurs with accelerated degradation in the melt. Elucidation of secondary decomposition pathways evidenced autocatalytic properties conferred by the formation of both isocyanic acid and methyl chloride. Finally, dynamic water vapor sorption analysis showed a substantial hygroscopicity of the drug substance. A deliquescent point has been determined at 56% relative humidity at 25 °C.< Réduire
Origine
Importé de halUnités de recherche